UK markets open in 5 hours 51 minutes
NIKKEI 225
38,092.14 -722.42 (-1.86%) HANG SENG
17,941.78 -170.82 (-0.94%) CRUDE OIL
78.34 -0.11 (-0.14%) GOLD FUTURES
2,341.40 -7.70 (-0.33%) DOW
38,589.16 -57.94 (-0.15%) Bitcoin GBP
52,444.63 +315.71 (+0.61%)
MorphoSys AG (MOR.HM)
Hamburg - Hamburg Delayed price. Currency in EUR
Add to watchlist
At close: 08:16AM CEST
| Previous close | 67.80 |
| Open | 67.10 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 67.10 - 67.10 |
| 52-week range | 15.48 - 70.00 |
| Volume | |
| Avg. volume | 81 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
Biogen's (BIIB) acquisition of private biotech, HI-Bio, is set to expand its rare disease pipeline by adding the latter's lead asset, felzartamab.
- Simply Wall St.
MorphoSys (ETR:MOR) shareholders have earned a 228% return over the last year
When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right...
- Zacks
Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
Novartis (NVS) enters into a license deal with Arvinas, Inc. (ARVN) for the worldwide development and commercialization of cancer candidate ARV-766. Shares of ARVN rise on the news.
© 2024 Yahoo. All rights reserved.